RA Capital Management as of Dec. 31, 2012
Portfolio Holdings for RA Capital Management
RA Capital Management holds 25 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 14.7 | $38M | 8.1M | 4.65 | |
| Dyax | 11.6 | $30M | 8.6M | 3.48 | |
| Sangamo Biosciences (SGMO) | 8.9 | $23M | 3.8M | 6.01 | |
| Achillion Pharmaceuticals | 8.4 | $22M | 2.7M | 8.01 | |
| Sunesis Pharmaceuticals | 8.0 | $20M | 4.9M | 4.20 | |
| Derma Sciences | 6.8 | $18M | 1.6M | 11.11 | |
| Insmed (INSM) | 6.4 | $16M | 2.4M | 6.69 | |
| XOMA CORP Common equity shares | 6.1 | $16M | 6.5M | 2.40 | |
| ArthroCare Corporation | 5.2 | $13M | 388k | 34.59 | |
| OncoGenex Pharmaceuticals | 4.6 | $12M | 894k | 13.12 | |
| Coronado Biosciences Inc. Common | 3.1 | $7.8M | 1.7M | 4.51 | |
| Illumina (ILMN) | 2.6 | $6.7M | 120k | 55.59 | |
| Senomyx | 2.6 | $6.7M | 4.0M | 1.68 | |
| Chemocentryx | 2.4 | $6.1M | 556k | 10.94 | |
| Cytori Therapeutics | 2.3 | $5.9M | 2.1M | 2.80 | |
| Mei Pharma | 1.6 | $4.1M | 587k | 7.00 | |
| INC Ventrus Biosciences | 1.1 | $2.7M | 1.3M | 2.16 | |
| ArQule | 1.0 | $2.6M | 928k | 2.79 | |
| Anacor Pharmaceuticals In | 0.8 | $2.2M | 421k | 5.20 | |
| Antares Pharma | 0.8 | $2.1M | 541k | 3.81 | |
| Newlink Genetics Corporation | 0.5 | $1.2M | 97k | 12.50 | |
| Synergy Pharmaceuticals | 0.3 | $838k | 159k | 5.26 | |
| Novavax | 0.1 | $189k | 100k | 1.89 | |
| Savient Pharmaceuticals note | 0.1 | $180k | 1.0M | 0.18 | |
| D Tranzyme | 0.0 | $114k | 211k | 0.54 |
